Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00329771 · ClinicalTrials.gov registry record

Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.

A clinical trial, sponsored by Thomas Jefferson University.

Completed
Registry status
28
Enrollment target

NCT00329771: Completed study, sponsored by Thomas Jefferson University.

NCT00329771 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00329771 has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
28 participants
Enrollment target

Study Summary

Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in migraine. It is a heightened skin sensitivity during an active migraine attack. Migraine attacks in patients who experience allodynia are more difficult to treat. This study intends to collect and evaluate data on the phenomenon of allodynia in patients with episodic migraine during an actual attack. The results of this study may help clinicians better understand allodynia, thereby helping them diagnose and more effectively manage patients with migraine and allodynia.

Primary Outcome

Brush allodynia (discomfort with normal sensation) measured at pre-specified sites on the head, neck and forearms using a 100 mm visual analog scale (VAS). After each series of brushes the patient will be asked to rate the level of discomfort from "normal sensation" to "extremely painful or unpleasant" using a 100 mm visual analog scale (VAS).

Interventions

  • OTHER No intervention: We are testing for the presence of allodynia

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2006-03
Est. Completion 2008-03
Thomas Jefferson University

292 total trials

What the finished NCT00329771 record still lists

NCT00329771 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which No intervention: We are testing for the presence of allodynia is the first listed.

NCT00329771 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00329771 about?

NCT00329771 is a clinical study titled "Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.". Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in migraine. It is a heightened skin sensitivity during an active migraine attack. Migraine attacks in patients who experience allodynia are more difficult to treat. This study intends to collect and evaluate data on the phenomen...

What is the current status of trial NCT00329771?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-03. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00329771?

The interventions under investigation include: No intervention: We are testing for the presence of allodynia (OTHER).

Who is sponsoring clinical trial NCT00329771?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00329771, the US trial registry maintained by the National Library of Medicine. NCT00329771 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.